Vitamin D-metabolizing enzyme CYP24A1 affects oncogenic behaviors of oral squamous cell carcinoma and its prognostic implication.
Anticancer drugs
Immunohistochemistry
Oncogenic property
Oral squamous cell carcinoma
Vitamin D
Vitamin D-metabolizing enzyme CYP24A1
Journal
Medical molecular morphology
ISSN: 1860-1499
Titre abrégé: Med Mol Morphol
Pays: Japan
ID NLM: 101239023
Informations de publication
Date de publication:
21 May 2024
21 May 2024
Historique:
received:
08
04
2024
accepted:
08
05
2024
medline:
22
5
2024
pubmed:
22
5
2024
entrez:
21
5
2024
Statut:
aheadofprint
Résumé
Vitamin D is an essential molecule for cellular homeostasis, playing a critical role in cell fate decisions including cell proliferation, differentiation, and viability. Accumulating evidence has revealed that expression of the vitamin D-metabolizing enzyme CYP24A1 is dysregulated in different types of human malignancy. CYP24A1 has been shown to be involved in the oncogenic property of a variety of carcinoma cells. However, the pathological relevance of CYP24A1 expression level in human oral malignancy remains to be clarified. In the present study, suppression of CYP24A1 expression in oral squamous cell carcinoma (OSCC) cells increased cell proliferation, invasive activity, colony formation efficacy, and tumor growth in vivo. In addition, knockout of CYP24A1 expression inhibited cell death induced by two different types of anticancer drugs, i.e., fluorouracil and cisplatin. Gene clustering by RNA-sequence analysis revealed that several signaling molecules associated with MYC are involved in CYP24A1-mediated oncogenic behaviors. Furthermore, decreased expression level of CYP24A1 was observed in 124/204 cases (61%) of OSCC and was shown to be associated with short relapse-free and overall survival periods. The results showed that a low expression level of CYP24A1 promotes the oncogenic activity of OSCC and is significantly associated with poor prognosis in patients with this malignancy.
Identifiants
pubmed: 38772955
doi: 10.1007/s00795-024-00387-y
pii: 10.1007/s00795-024-00387-y
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024. The Author(s) under exclusive licence to The Japanese Society for Clinical Molecular Morphology.
Références
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71:209–249
doi: 10.3322/caac.21660
Abati S, Bramati C, Bondi S, Lissoni A, Trimarchi M (2020) Oral cancer and precancer: a narrative review on the relevance of early diagnosis. Int J Environ Res Public Health 17:9160
doi: 10.3390/ijerph17249160
Picon H, Guddati AK (2020) Mechanisms of resistance in head and neck cancer. Am J Cancer Res 10:2742–2751
The Cancer Genome Atlas Network (2015) Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature 517:576–582
doi: 10.1038/nature14129
Bikle DD (2014) Vitamin D metabolism, mechanism of action, and clinical applications. Chem Biol 21:319–329
doi: 10.1016/j.chembiol.2013.12.016
Bouillon R, Marcocci C, Carmeliet G, Bikle D, White JH, Dawson-Hughes B, Lips P, Munns CF, Lazaretti-Castro M, Giustina A, Bilexikian J (2019) Skeletal and extraskeletal actions of vitamin D: current evidence and outstanding questions. Endocr Rev 40:1109–1151
doi: 10.1210/er.2018-00126
Christakos S, Dhawan P, Verstuyf A, Verlinden L, Carmeliet G (2016) Vitamin D: metabolism, molecular mechanism of action, and pleiotropic effects. Physiol Rev 96:365–408
doi: 10.1152/physrev.00014.2015
Saponaro F, Saba A, Zucchi R (2020) An update on vitamin D metabolism. Int J Mol Sci 21:6573
doi: 10.3390/ijms21186573
Fernández-Barral A, Bustamante-Madrid P, Ferrer-Mayorga G, Barbáchano A, Larriba MJ, Muñoz A (2020) Vitamin D effects on cell differentiation and stemness in cancer. Cancers 12:2413
doi: 10.3390/cancers12092413
Jeon SM, Shin EA (2018) Exploring vitamin D metabolism and function in cancer. Experimental & Mol Med 50:20
doi: 10.1038/s12276-018-0038-9
Trump DL, Aragon-Ching JB (2018) Vitamin D in prostate cancer. Asian J Androl 20:244–252
doi: 10.4103/aja.aja_14_18
Song ZY, Yao Q, Zhuo Z, Ma Z, Chen G (2018) Circulating vitamin D level and mortality in prostate cancer patients: a dose-response meta-analysis. Endocr Connect 7:R294–R303
doi: 10.1530/EC-18-0283
Dou R, Ng K, Giovannucci EL, Manson JE, Qian ZR, Ogino S (2016) Vitamin D and colorectal cancer: molecular, epidemiological, and clinical evidence. Br J Nutr 115:1643–1660
doi: 10.1017/S0007114516000696
Grimm M, Cetindis M, Biegner T, Lehman M, Munz A, Teriete P, Reinert S (2015) Serum vitamin D levels of patients with oral squamous cell carcinoma (OSCC) and expression of vitamin D receptor in oral precancerous lesions and OSCC. Med Oral Patol Oral Cir Bucal 20:e188–e195
doi: 10.4317/medoral.20368
Razak S, Afsar T, Almajwal A, Alam I, Jahan S (2019) Growth inhibition and apoptosis in colorectal cancer cells induced by Vitamin D-Nanoemulsion (NVD): involvement of Wnt/β-catenin and other signal transduction pathways. Cell Biosci 9:15
doi: 10.1186/s13578-019-0277-z
Fathi N, Ahmadian E, Shahi S, Roshangar L, Khan H, Kouhsoltani M, Dizaj SM, Sharifi S (2019) Role of vitamin D and vitamin D receptor (VDR) in oral cancer. Biomed Pharmacother 109:391–401
doi: 10.1016/j.biopha.2018.10.102
Negri M, Gentile A, de Angelis C, Montò T, Patalano R, Colao A, Pivonello R, Pivonello C (2020) Vitamin D-induced molecular mechanisms to potentiate cancer therapy and to reverse drug-resistance in cancer cells. Nutrients 12:1798
doi: 10.3390/nu12061798
Shiratsuchi H, Wang Z, Chen G, Ray P, Lin J, Zhang Z, Zhao L, Beer D, Ray D, Ramnath N (2017) Oncogenic potential of CYP24A1 in lung adenocarcinoma. J Thorac Oncol 12:269–280
doi: 10.1016/j.jtho.2016.10.010
Mimori K, Tanaka Y, Yoshinaga K, Masuda T, Yamashita K, Okamoto M, Inoue H, Mori M (2004) Clinical significance of the overexpression of the candidate oncogene CYP24 in esophageal cancer. Ann of Oncol 15:236–241
doi: 10.1093/annonc/mdh056
Anderson MG, Nakane M, Ruan X, Kroeger PE, Wu-Wong JR (2006) Expression of VDR and CYP24A1 mRNA in human tumors. Cancer Chemother Pharmacol 57:234–240
doi: 10.1007/s00280-005-0059-7
Brożyna AA, Jochymski C, Janjetovic Z, Jożwicki W, Tuckey RC, Slominski AT (2014) CYP24A1 expression inversely correlates with melanoma progression: clinic-pathological studies. Int J Mol Sci 15:19000–19017
doi: 10.3390/ijms151019000
Clinckspoor I, Hauben E, Verlinden L, Bruel AV, Vanwalleghem L, Poorten VV, Delaere P, Mathieu C, Verstuyf A, Decallonne B (2012) Altered expression of key players in vitamin D metabolism and signaling in malignant and benign thyroid tumors. J Histochem Cytochem 60:502–511
doi: 10.1369/0022155412447296
Osanai M, Lee GH (2016) CYP24A1-induced vitamin D insufficiency promotes breast cancer growth. Oncol Rep 36:2755–2762
doi: 10.3892/or.2016.5072
Kamiya S, Nakamori Y, Takasawa A, Takasawa K, Kyuno D, Ono Y, Magara K, Osanai M (2023) Suppression of the vitamin D metabolizing enzyme CYP24A1 provides increased sensitivity to chemotherapeutic drugs in breast cancer. Oncol Rep 49:85
doi: 10.3892/or.2023.8522
Magara K, Takasawa A, Osanai M, Ota M, Tagami Y, Ono Y, Takasawa K, Murata M, Hirohashi Y, Miyajima M, Yamada G, Hasegawa T, Sawada N (2017) Elevated expression of JAM-A promotes neoplastic properties of lung adenocarcinoma. Cancer Sci 108:2306–2314
doi: 10.1111/cas.13385
International Agency for Research on Cancer (2017) WHO classification of head and neck tumors (4th edition). El-Naggar AK, Chan JKC, Grandis JR, Takata T, Slootweg PJ (eds), Lyon, p.105–131
The Union for International Cancer Control (2016) TNM classification of malignant tumours, 8th edition. Brierley JD, Gospodarowicz MK, Wittekind C (eds). Wiley-Blackwell, p.17–53.
Japanese Society of Oral Oncology (2019) General rules for clinical and pathological studies on oral cancer (2nd edition). Ota Y (eds). Kanehara&CO, p.101–102.
Jin T, Guo Y, Huang Z, Zhang Q, Huang Z, Zhang Y, Huang Z (2020) Vitamin D inhibits the proliferation of oral squamous cell carcinoma by suppressing lncRNA LUCAT1 through the MAPK pathway. J Cancer 11:5971–5981
doi: 10.7150/jca.45389
Shintani T, Takatsu F, Rosli SNZ, Usui E, Hamada A, Sumi K, Hayashido Y, Toratani S, Okamoto T (2017) Eldecalcitol (ED-71), an analog of 1α,25(OH)
doi: 10.1007/s11626-017-0183-9
Huang Z, Zhang Y, Li H, Zhou Y, Zhang Q, Chen R, Jin T, Hu K, Li S, Wang Y, Chen W, Huang Z (2019) Vitamin D promotes the cisplatin sensitivity of oral squamous cell carcinoma by inhibiting LCN2-modulated NF-κB pathway activation through RPS3. Cell Death Dis 10:936
doi: 10.1038/s41419-019-2177-x
Slominski AT, Chaiprasongsuk A, Janjetovic Z, Kim TK, Stefan J, Slominski RM, Hanumanthu VS, Raman C, Qayyum S, Song Y, Song Y, Panich U, Crossman DK, Athar M, Holick MF, Jetten AM, Zmijewski MA, Zmijewski J, Tuckey RC (2020) Photoprotective Properties of Vitamin D and Lumisterol Hydroxyderivatives. Cell Biochem Biophys 78:165–180
doi: 10.1007/s12013-020-00913-6
Slominski AT, Li W, Kim TK, Semak I, Wang J, Zjawiony JK, Tuckey RC (2015) Novel activities of CYP11A1 and their potential physiological significance. J Steroid Biochem Mol Biol 151:25–37
doi: 10.1016/j.jsbmb.2014.11.010
Slominski AT, Kim TK, Li W, Postlethwaite A, Tieu EW, Tang EKY, Tuckey RC (2015) Detection of novel CYP11A1-derived secosteroids in the human epidermis and serum and pig adrenal gland. Sci Rep 5:14875
doi: 10.1038/srep14875
Academic Press (2024) Feldman and Pike's Vitamin D (5
Slominski AT, Brożyna AA, Kim TK, Elsayed MM, Janjetovic Z, Qayyum S, Slominski RM, Oak ASW, Li C, Podgorska E, Li W, Jetten AM, Tuckey RC, Tang EKY, Elmets C, Athar M (2022) CYP11A1-derived vitamin D hydroxyderivatives as candidates for therapy of basal and squamous cell carcinomas. Int J Oncol 61:96
doi: 10.3892/ijo.2022.5386
Jayanthi P, Varun BR, Selvaraj J (2020) Epithelial-mesenchymal transition in oral squamous cell carcinoma: An insight into molecular mechanisms and clinical implications. J Oral Maxillofac Pathol 24(1):189
doi: 10.4103/jomfp.JOMFP_334_19
Ghantous Y, Mozalbat S, Nashef A, Abdol-Elraziq M, Sudri S, Araidy S, Tadmor H, Abu El-naaj I (2024) EMT Dynamics in Lymph Node Metastasis of Oral Squamous Cell Carcinoma. Cancers 16:1185
doi: 10.3390/cancers16061185
Yu M, Wu H, Wang J, Chen X, Pan J, Liu P, Zhang J, Chen Y, Zhu W, Tang C, Jin Q, Li C, Lu C, Zeng H, Yu C, Sun J (2021) Vitamin D receptor inhibits EMT via regulation of the epithelial mitochondrial function in intestinal fibrosis. J Biol Cham 296:100531
doi: 10.1016/j.jbc.2021.100531
Ricca C, Aillon A, Viano M, Bergandi L, Aldieri E, Silvagno F (2019) Vitamin D inhibits the epithelial-mesenchymal transition by a negative feedback regulation of TGF-β activity. J Steroid Biochem Mol Biol 187:97–105
doi: 10.1016/j.jsbmb.2018.11.006
Wang P, Xu J, You W, Hou Y, Wang S, Ma Y, Tan J, Zhang Z, Hu W, Li B (2020) Knockdown of CYP24A1 aggravates 1α,25(OH)
doi: 10.3389/fonc.2020.01258
Hu N, Zhang H (2018) CYP24A1 depletion facilitates the antitumor effect of vitamin D3 on thyroid cancer cells. Exp Ther Med 16:2821–2830
Yasuda K, Nishikawa M, Okamoto K, Horibe K, Mano H, Yamaguchi M, Okon R, Nakagawa K, Tsugawa N, Okano T, Kawagoe F, Kittaka A, Ikushiro S, Sasaki T (2021) Elucidation of metabolic pathways of 25-hydroxyvitamin D3 mediated by CYP24A1 and CYP3A using Cyp24a1 knockout rats generated by CRISPR/Cas9 system. J Biol Chem 296:100668
doi: 10.1016/j.jbc.2021.100668
Zeljic K, Supic G, Radak MS, Jovic N, Kozomara R, Magic Z (2012) Vitamin D receptor, CYP27B1 and CYP24A1 genes polymorphisms association with oral cancer risk and survival. J Oral Pathol Med 41:779–787
doi: 10.1111/j.1600-0714.2012.01164.x
Azad AK, Bairati I, Qiu X, Huang H, Cheng D, Liu G, Meyer F, Adjei A, Xu W (2013) Genetic sequence variants in vitamin D metabolism pathway genes, serum vitamin D level and outcome in head and neck cancer patients. Int J Cancer 132:2520–2527
doi: 10.1002/ijc.27946